Piper Sandler Upgrades Alpha Tau Medical (DRTS) to Overweight
Alpha Tau Medical (DRTS) shares saw upward momentum on Wednesday following an upgrade by Piper Sandler. The analyst firm raised the stock's rating from Neutral to Overweight, signaling increased confidence in the company's near-term trajectory. Piper Sandler analyst Allison Bratzel highlighted a 'catalyst-rich period' expected for the oncology therapeutics company over the next 12 months. This outlook suggests that upcoming clinical or commercial milestones could serve as significant drivers for the stock's performance.
Tickers: $DRTS
Topics: analyst rating oncology therapeutics stock upgrade
Read the full article at Seeking Alpha
Part of the story Alpha Tau upgraded at Piper Sandler on catalyst path (2 articles)